2.5.13 Leukotriene pathway inhibition 2.5.13.1 Lys006 Leukotriene A4 hydrolase (LTA4H) generates leukotriene B4, a potent chemoattractant for neutrophils that amplifies acute inflammation, and inhibiting this enzyme aims to reduce neutrophil-driven tissue damage in UC
Novo Nordisks key patents for semaglutide (used in Ozempic and Wegovy) in India are scheduled to expire in March 2026
Increasing consumer awareness regarding preventive healthcare and wellness optimization, rising demand for skin-brightening and anti-aging treatments, growing adoption of antioxidant therapies, advancements in intravenous infusion technologies, and the expanding popularity of personalized wellness solutions are creating substantial growth opportunities for the Global IV Glutathione Treatment Market Market Overview The Global IV Glutathione Treatment Market includes the production, promotion, and application of glutathione-based treatments administered intravenously, extensively used for antioxidant purposes, detoxification, liver function improvement, immune system boosting, anti-aging effects, and skin-related aesthetics
To confirm the effect of GLP-1R and PI3K/Akt in CM, a GLP-1R selective agonist (liraglutide) and antagonist (exendin(939)) and a PI3K selective antagonist (LY294002) were administered